We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Grifols’ Convalescent Plasma COVID-19 Therapy Begins Trial
Spanish drugmaker Grifols has begun a late-stage trial to evaluate its anti-coronavirus hyperimmune globulin, which is derived from the plasma of recovered COVID-19 patients.